AWM
GSK icon

AE Wealth Management’s GSK GSK Stock Holding History

AE Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Sell
23,359
-8,466
-27% -$459K 0.01% 773
2025
Q4 		$1.56M Sell
31,825
-735
-2% -$34.3K 0.01% 683
2025
Q3 		$1.41M Buy
32,560
+3,112
+11% +$122K 0.01% 666
2025
Q2 		$1.13M Buy
29,448
+8,137
+38% +$311K 0.01% 696
2025
Q1 		$826K Buy
21,311
+1,316
+7% +$48.2K 0.01% 760
2024
Q4 		$676K Buy
19,995
+234
+1% +$8.42K 0.01% 812
2024
Q3 		$808K Sell
19,761
-108
-0.5% -$4.42K 0.01% 756
2024
Q2 		$765K Buy
19,869
+815
+4% +$34.3K 0.01% 775
2024
Q1 		$817K Sell
19,054
-32,020
-63% -$1.32M 0.01% 701
2023
Q4 		$2M Buy
51,074
+8,021
+19% +$288K 0.01% 910
2023
Q3 		$1.56M Sell
43,053
-189
-0.4% -$6.71K 0.01% 930
2023
Q2 		$1.54M Sell
43,242
-64,615
-60% -$2.32M 0.01% 929
2023
Q1 		$3.84M Buy
107,857
+7,852
+8% +$275K 0.02% 570
2022
Q4 		$3.51M Buy
100,005
+2,302
+2% +$76.7K 0.03% 566
2022
Q3 		$2.88M Buy
97,703
+5,598
+6% +$212K 0.02% 585
2022
Q2 		$5.01M Buy
92,105
+20,843
+29% +$1.15M 0.04% 410
2022
Q1 		$3.88M Sell
71,262
-5
-0% -$272 0.03% 519
2021
Q4 		$3.93M Buy
71,267
+4,052
+6% +$211K 0.03% 487
2021
Q3 		$3.21M Buy
67,215
+15,117
+29% +$759K 0.03% 497
2021
Q2 		$2.59M Buy
52,098
+23,591
+83% +$1.13M 0.02% 559
2021
Q1 		$1.27M Sell
28,507
-34,515
-55% -$1.57M 0.01% 698
2020
Q4 		$2.9M Sell
63,022
-12,364
-16% -$568K 0.03% 387
2020
Q3 		$3.55M Sell
75,386
-1,265
-2% -$63.4K 0.05% 288
2020
Q2 		$3.91M Buy
76,651
+9,883
+15% +$507K 0.06% 266
2020
Q1 		$3.16M Sell
66,768
-3,440
-5% -$183K 0.07% 228
2019
Q4 		$4.12M Buy
70,208
+8,498
+14% +$473K 0.09% 208
2019
Q3 		$3.29M Sell
61,710
-14,032
-19% -$722K 0.1% 191
2019
Q2 		$3.79M Buy
75,742
+39,341
+108% +$1.97M 0.11% 156
2019
Q1 		$1.9M Buy
36,401
+4,591
+14% +$229K 0.13% 143
2018
Q4 		$1.52M Sell
31,810
-17,053
-35% -$840K 0.26% 100
2018
Q3 		$2.45M Buy
48,863
+24,257
+99% +$1.23M 0.14% 119
2018
Q2 		$1.24M Buy
24,606
+3,704
+18% +$187K 0.08% 140
2018
Q1 		$1.02M Buy
20,902
+1,751
+9% +$81.5K 0.08% 161
2017
Q4 		$849K Sell
19,151
-5,003
-21% -$231K 0.07% 185
2017
Q3 		$1.23M Sell
24,154
-1,414
-6% -$71.7K 0.11% 118
2017
Q2 		$1.38M Buy
25,568
+10,218
+67% +$545K 0.16% 111
2017
Q1 		$809K Buy
15,350
+3,810
+33% +$193K 0.15% 134
2016
Q4 		$556K Buy
+11,540
New +$570K 0.23% 107

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AE Wealth Management's GSK Position: Q1 2026 in Review

AE Wealth Management reduced its GSK (GSK) stake by 27% in Q1 2026, selling an estimated $459K and leaving 23,359 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #773.

AE Wealth Management first reported a position in GSK in Q4 2016 and has held it in 38 quarters since. The position peaked at $5.01M in Q2 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • AE Wealth Management held 23,359 shares of GSK worth $1.29M as of Q1 2026.
  • AE Wealth Management sold 8,466 GSK shares in Q1 2026, an estimated $459K.
  • GSK made up 0.01% of AE Wealth Management's portfolio in Q1 2026, its #773 holding.
  • AE Wealth Management first reported a position in GSK in Q4 2016 and has held it in 38 quarters since.
  • AE Wealth Management's GSK position peaked at $5.01M in Q2 2022.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.